Cyclica Inc.

Cyclica Inc.
Company Size
Startup (1-19)

Cyclica helps pharmaceutical companies navigate the drug discovery pipeline by assessing the safety and efficacy of drugs. Whether pre-clinical, clinical, or FDA approved, Cyclica's in-house, drug-centric and structure-based bioinformatics platform, Ligand Express™ offers novel insight and analysis into a drugs’ effects.

By focusing on a small molecule structure and its polypharmacological profile, we distinguish ourselves with virtual screening technologies that are specific for a protein structure. We further augment our structural information with cognitive computing to drive our biophysical simulations.

Unlike deep-learning approaches that explore the limited space of established drug targets, our technology generates novel predictions that include conventional targets and beyond.

Cyclica's pre-clinical insights and in silico predictions improve current attrition rates of lead therapeutic compounds, improve patient outcomes with fewer side effects, and breathe life back into shelved therapeutics.

Email me jobs from this employer
Get new jobs for this search by email

When you create this job alert we will email you a selection of jobs matching your criteria. Our Terms and Conditions and Privacy Policy apply to this service.

Other marketing communication

We'd love to send you information about jobs and services from by email.

All emails will contain a link in the footer to enable you to unsubscribe at any time.